INBP reports 22% drop in quarterly revenue
Integrated BioPharma reported a 22% decrease in revenue to $9.9 million for Q3 2026 due primarily to lower performance from its two largest customers in the Contract Manufacturing Segment, resulting in an operating loss of $961,000.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed